Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 4;1(1):31-39.
doi: 10.1016/j.imj.2021.08.001. eCollection 2022 Mar.

Global trends in COVID-19

Affiliations
Review

Global trends in COVID-19

Chuan-Min Zhou et al. Infect Med (Beijing). .

Abstract

The pandemic COVID-19 is certainly one of the most severe infectious diseases in human history. In the last 2 years, the COVID-19 pandemic has caused over 418.6 million confirmed cases and 5.8 million deaths worldwide. Young people make up the majority of all infected COVID-19 cases, but the mortality rate is relatively lower compared to older age groups. Currently, about 55.04% individuals have been fully vaccinated rapidly approaching to herd immunity globally. The challenge is that new SARS-CoV-2 variants with potential to evade immunity from natural infection or vaccine continue to emerge. Breakthrough infections have occurred in both SARS-CoV-2 naturally infected and vaccinated individuals, but breakthrough infections tended to exhibit mild or asymptomatic symptoms and lower mortality rates. Therefore, immunity from natural infection or vaccination can reduce SARS-CoV-2 pathogenicity, but neither can completely prevent SARS-CoV-2 infection/reinfection. Fortunately, the morbidity and mortality of COVID-19 continue to decline. The 7-day average cumulative case fatality of COVID-19 has decreased from 12.3% on the February 25, 2020, to 0.27% on January 09, 2022, which could be related to a decreased SARS-CoV-2 variant virulence, vaccine immunization, and/or better treatment of patients. In conclusion, elimination of SARS-CoV-2 in the world could be impossible or at least an arduous task with a long way to go. The best strategy to prevent COVID-19 pandemic is to expand inoculation rate of effective vaccines. As the population reaches herd immunity, the mortality rate of COVID-19 may continue to decrease, and COVID-19 could eventually become another common cold.

Keywords: Breakthrough infection; COVID-19; Case fatality rate; Delta variant; Herd immunity; Omicron variant; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig 1
Fig. 1
Top 25 Countries with cumulative cases per 100,000 population as of February 18, 2022 (https://covid19.who.int/). (Color version of figure is available online).
Fig 2
Fig. 2
Top 25 Countries with cumulative cases per 100,000 population from February 12, 2022 to February 18, 2022 (https://covid19.who.int/). (Color version of figure is available online).
Fig 3
Fig. 3
Top 25 Countries with cumulative deaths per 100,000 population as of February 18, 2022 (https://covid19.who.int/). (Color version of figure is available online).
Fig 4
Fig. 4
Distribution of COVID-19 cases, deaths, and CFR in different age groups in the United States as of February 18, 2022 (https://covid.cdc.gov/covid-data-tracker/#datatracker-home). (Color version of figure is available online).
Fig 5
Fig. 5
Worldwide 7-day average CFR of COVID-19 from January 22, 2020, to January 9, 2022 (https://www.worldometers.info/coronavirus/). (Color version of figure is available online).
Fig 6
Fig. 6
Worldwide 7-day average COVID-19 cases and deaths as of January 9, 2022 (https://www.worldometers.info/coronavirus/). (Color version of figure is available online).

Similar articles

Cited by

References

    1. Fung T.S., Liu D.X. Human coronavirus: host-pathogen interaction. Annu Rev Microbiol. 2019;73:529–557. - PubMed
    1. Guan Y., Zheng B.J., He Y.Q., et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–278. - PubMed
    1. Zhong N.S., Zheng B.J., Li Y.M., et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003. Lancet. 2003;362:1353–1358. - PMC - PubMed
    1. Zaki A.M., van Boheemen S., Bestebroer T.M., et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. - PubMed
    1. Zhu N., Zhang D., Wang W., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. - PMC - PubMed